letermovir (prevymis) Report issue

Small molecule Orphan Drug FDA Approved FDA First in Class Fast Track FDA Priority Review FDA
AACT DrugBank Drugs@FDA PubChem
Back

Drug Pricing Summary

VA Big4

$8.7000 - $151.4671

VA FSS

$11.4033 - $197.6579

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
letermovir 20 mg / 1 mL (1 mL INJECTION) $8.7000 VA Big4
  • PREVYMIS (24)
    		•  Merck Sharp & Dohme Corporation
    letermovir 20 mg / 1 mL (1 mL INJECTION) $11.4033 VA FSS
  • PREVYMIS (24)
    		•  Merck Sharp & Dohme Corporation
    letermovir 20 mg / 1 mL (1 mL INJECTION) $18.2975 VA Big4
  • PREVYMIS (12)
    		•  Merck Sharp & Dohme Corporation
    letermovir 20 mg / 1 mL (1 mL INJECTION) $22.8067 VA FSS
  • PREVYMIS (12)
    		•  Merck Sharp & Dohme Corporation
    letermovir 240 mg (TABLET) $150.4636 VA Big4
  • PREVYMIS (28)
    		•  Merck Sharp & Dohme Corporation
    letermovir 240 mg (TABLET) $151.3257 VA Big4
  • PREVYMIS (14)
    		•  Merck Sharp & Dohme Corporation
    letermovir 240 mg (TABLET) $196.0404 VA FSS
  • PREVYMIS (28)
    		•  Merck Sharp & Dohme Corporation
    letermovir 240 mg (TABLET) $197.6579 VA FSS
  • PREVYMIS (14)
    		•  Merck Sharp & Dohme Corporation
    letermovir 480 mg (TABLET) $150.6721 VA Big4
  • PREVYMIS (28)
    		•  Merck Sharp & Dohme Corporation
    letermovir 480 mg (TABLET) $151.4671 VA Big4
  • PREVYMIS (14)
    		•  Merck Sharp & Dohme Corporation
    letermovir 480 mg (TABLET) $196.0404 VA FSS
  • PREVYMIS (28)
    		•  Merck Sharp & Dohme Corporation
    letermovir 480 mg (TABLET) $197.6579 VA FSS
  • PREVYMIS (14)
    		•  Merck Sharp & Dohme Corporation

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue